RKL Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $394K | Sell |
|
|||||
|
2023
Q4 | $2.13M | Buy |
|
|||||
|
2023
Q3 | $2.06M | Sell |
|
|||||
|
2023
Q2 | $2.3M | Buy |
|
|||||
|
2023
Q1 | $2.48M | Sell |
|
|||||
|
2022
Q4 | $2.59M | Buy |
|
|||||
|
2022
Q3 | $2.55M | Sell |
|
|||||
|
2022
Q2 | $2.76M | Buy |
|
|||||
|
2022
Q1 | $2.58M | Buy |
|
|||||
|
2021
Q4 | $2.15M | Buy |
|
|||||
|
2021
Q3 | $2M | Sell |
|
|||||
|
2021
Q2 | $2.3M | Buy |
|
|||||
|
2021
Q1 | $2.11M | Sell |
|
|||||
|
2020
Q4 | $2.21M | Sell |
|
|||||
|
2020
Q3 | $2.16M | Sell |
|
|||||
|
2020
Q2 | $2.11M | Buy |
|
|||||
|
2020
Q1 | $1.94M | Sell |
|
|||||
|
2019
Q4 | $2.29M | Buy |
|
|||||
|
2019
Q3 | $1.43M | Buy |
|
|||||
|
2019
Q2 | $1.22M | Sell |
|
|||||
|
2019
Q1 | $1.34M | Buy |
|
|||||
|
2018
Q4 | $1.41M | Sell |
|
|||||
|
2018
Q3 | $1.68M | Buy |
|
|||||
|
2018
Q2 | $1.48M | Sell |
|
|||||
|
2018
Q1 | $1.79M | Buy |
|
|||||
|
2017
Q4 | $1.63M | Sell |
|
|||||
|
2017
Q3 | $1.7M | Buy |
|
|||||
|
2017
Q2 | $1.31M | Buy |
|
|||||
|
2017
Q1 | $958K | Buy |
|
|||||
|
2016
Q4 | $603K | Buy |
|
|||||
|
2016
Q3 | $405K | Buy |
|
|||||
|
2016
Q2 | $400K | Buy |
|
|||||
|
2016
Q1 | $319K | Buy |
|